Idi na sadržaj

Onkologija

Multimodalni, interdisciplinarni i individualizirani pristup

Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's Witness: a strategy to avoid transfusion. (otvara se novi prozor)

Barakat O, Cooper JR Jr, Riggs SA, Hoef JW, Ozaki CF, Wood RP.

Izvor‎: J Surg Oncol 2007;96(3):249-53.

Indeks‎: PubMed 17443725

DOI‎: 10.1002/jso.20799

https://www.ncbi.nlm.nih.gov/pubmed/17443725 (otvara se novi prozor)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (otvara se novi prozor)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Izvor‎: Transfusion 2016;56(10):2438-42.

Indeks‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (otvara se novi prozor)

Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. (otvara se novi prozor)

Gross I, Trentino KM, Andreescu A, Pierson R, Maietta RA, Farmer S.

Izvor‎: Oncologist 2016;21(3):327-32.

Indeks‎: PubMed 26865590

DOI‎: 10.1634/theoncologist.2015-0406

https://www.ncbi.nlm.nih.gov/pubmed/26865590 (otvara se novi prozor)

Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (otvara se novi prozor)

Konstantinidis IT, Allen PJ, D'Angelica MI, Dematteo RP, Fischer ME, Grant F, Fong Y, Kingham TP, Jarnagin WR.

Izvor‎: J Am Coll Surg 2013;217(6):1101-7.

Indeks‎: PubMed 23880361

DOI‎: 10.1016/j.jamcollsurg.2013.05.020

https://www.ncbi.nlm.nih.gov/pubmed/23880361 (otvara se novi prozor)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (otvara se novi prozor)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Izvor‎: Leuk Res Rep. 2022 25;18:100355.

Indeks‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (otvara se novi prozor)